Jose Abdenur
Clinical Biochemical Genetics · Orange, CANPI 1154428027
Payments from drug & device makers
Across 70 payments — averaging $8580.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ultragenyx Pharmaceutical Inc.$582K
- Saol International Limited$19K
- Travere Therapeutics, Inc.$27
- Alnylam Pharmaceuticals Inc.$19
What the payments were for
- Consulting fees$6,40097%
- Education$1673%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 53 | $582,030 |
| Saol International Limited | 10 | $18,579 |
| Travere Therapeutics, Inc. | 6 | $27 |
| Alnylam Pharmaceuticals Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DOJOLVI$6,400
How this compares
Too few clinical biochemical genetics providers in Californiato place this figure against a meaningful peer group, so we don't.
Other clinical biochemical genetics in Orange
- Divya VatsLos Angeles$234K
- Bruce BarshopSan Diego$201K
- David DimmockSan Diego$3K
- Kristina Cusmano OzogStanford$174
- Jaime BareaMadera$18
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.